THALOMID (thalidomide)
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · ERYTHEMA NODOSUM LEPROSUM ·+2
CELGENE/BMS
Drug class
Thalidomide and Derivative Immunomodulators
Thalidomide and derivative immunomodulators, commonly referred to as immunomodulatory drugs (IMiDs), are a distinct class of synthetic oral compounds that modify immune system activity, inhibit angiogenesis, and exert direct antiproliferative and cytotoxic effects against malignant cells. Read more about Thalidomide and Derivative Immunomodulators
30 drugs in this class 21 manufacturers
Drugs in Thalidomide and Derivative Immunomodulators
REVLIMID (lenalidomide)
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · MULTIPLE MYELOMA ·+6
CELGENE/BMS
POMALYST (pomalidomide)
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · KAPOSI'S SARCOMA ·+1
CELGENE/BMS
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · MULTIPLE MYELOMA ·+6
Mylan Pharmaceuticals
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · MULTIPLE MYELOMA ·+6
TEVA PHARM
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · MULTIPLE MYELOMA ·+6
CAMBER PHARMACE
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · MULTIPLE MYELOMA ·+6
ALVOGEN INC
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · MULTIPLE MYELOMA ·+6
DR.REDDY'S LAB
LENALIDOMIDE
THALIDOMIDE AND DERIVATIVE IMMUNOMODULATORS · MULTIPLE MYELOMA ·+6
APOTEX CORP
Filter & compare in the drug finder →
Opens the drug finder with Thalidomide and Derivative Immunomodulators preselected. Add indication or manufacturer filters there.
Thalidomide and derivative immunomodulators, commonly referred to as immunomodulatory drugs (IMiDs), are a distinct class of synthetic oral compounds that modify immune system activity, inhibit angiogenesis, and exert direct antiproliferative and cytotoxic effects against malignant cells.
These agents, which include thalidomide and its analogues lenalidomide and pomalidomide, primarily function by binding the E3 ubiquitin ligase component cereblon (CRBN), prompting the targeted ubiquitination and proteasomal degradation of critical lymphoid transcription factors.
Therapeutically, this drug class is predominantly employed in hematologic oncology to treat multiple myeloma and myelodysplastic syndromes, as well as in dermatologic manifestations of inflammatory conditions such as erythema nodosum leprosum.
-
brainkart.com
Thalidomide and derivative immunomodulators, commonly referred to as immunomodulatory drugs (IMiDs), are a distinct class of synthetic oral compounds that modify immune system activity, inhibit angiogenesis, and exert direct antiproliferative and cytotoxic effects against malignant cells Therapeutically, this drug class is predominantly employed in hematologic oncology to treat multiple myeloma and myelodysplastic syndromes, as well as in dermatologic manifestations of inflammatory conditions su...
-
nih.gov
Thalidomide and derivative immunomodulators, commonly referred to as immunomodulatory drugs (IMiDs), are a distinct class of synthetic oral compounds that modify immune system activity, inhibit angiogenesis, and exert direct antiproliferative and cytotoxic effects against malignant cells
-
nih.gov
These agents, which include thalidomide and its analogues lenalidomide and pomalidomide, primarily function by binding the E3 ubiquitin ligase component cereblon (CRBN), prompting the targeted ubiquitination and proteasomal degradation of critical lymphoid transcription factors
-
nih.gov
These agents, which include thalidomide and its analogues lenalidomide and pomalidomide, primarily function by binding the E3 ubiquitin ligase component cereblon (CRBN), prompting the targeted ubiquitination and proteasomal degradation of critical lymphoid transcription factors
-
nih.gov
These agents, which include thalidomide and its analogues lenalidomide and pomalidomide, primarily function by binding the E3 ubiquitin ligase component cereblon (CRBN), prompting the targeted ubiquitination and proteasomal degradation of critical lymphoid transcription factors
-
nih.gov
Therapeutically, this drug class is predominantly employed in hematologic oncology to treat multiple myeloma and myelodysplastic syndromes, as well as in dermatologic manifestations of inflammatory conditions such as erythema nodosum leprosum
-
jddonline.com
Therapeutically, this drug class is predominantly employed in hematologic oncology to treat multiple myeloma and myelodysplastic syndromes, as well as in dermatologic manifestations of inflammatory conditions such as erythema nodosum leprosum
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.